Apabetalone
- Generic Name
- Apabetalone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H22N2O5
- CAS Number
- 1044870-39-4
- Unique Ingredient Identifier
- 8R4A7GDZ1D
- Background
Apabetalone has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.
- Associated Conditions
- -
- Associated Therapies
- -
QU scientists in precision medicine breakthrough
Qatar University scientists developed Apabetalone, an epigenetic therapy targeting gene regulation for treating chronic diseases, granted FDA breakthrough designation. Led by Dr. Zaid al-Ma'ayah, the study, published in Pharmacology and Translational Science, explores Apabetalone's potential in cardiovascular, renal, neurological, viral, and cancer disorders, funded by QU.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath